GENELUX Corp
For the period ended Jun 30, 2026. Filed Aug 13, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2026 · Filed Aug 13, 2026
GNLX$1.95-5.8%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Statements of Stockholders’ Equity
(in thousands, except share amounts)
| Common Stock · Treasury Stock · Additional Paid-in · Accumulated Other Comprehensive · Accumulated | ||||||||
|---|---|---|---|---|---|---|---|---|
| Shares | Amount | Shares | Amount | Capital | Income (Loss) | Deficit | Total | |
| Balance, December 31, 2025 | 38,139,144 | $38 | (433,333) | $(433) | $295,468 | $9 | $(283,538) | $11,544 |
| Fair value of vested options | - | - | - | - | 1,394 | - | - | 1,394 |
| Unrealized loss on marketable securities | - | - | - | - | - | (14) | - | (14) |
| Fair value of vested restricted stock units | 29,063 | - | - | - | 319 | - | - | 319 |
| Cost of stock option modifications and repricing | - | - | - | - | 68 | - | - | 68 |
| Issuance of common stock for cash | 6,666,667 | 7 | - | - | 18,518 | - | - | 18,525 |
| Issuance of common stock upon exercise of stock options | 5,542 | - | - | - | 13 | - | - | 13 |
| Net loss during the three months ended March 31, 2026 | - | - | - | - | - | - | (8,928) | (8,928) |
| Balance, March 31, 2026 | 44,840,416 | $45 | (433,333) | $(433) | $315,780 | $(5) | $(292,466) | $22,921 |
| Fair value of vested options | - | - | - | - | 1,417 | - | - | 1,417 |
| Unrealized gain on marketable securities | - | - | - | - | - | 3 | - | 3 |
| Fair value of vested restricted stock units | 123,965 | - | - | - | 782 | - | - | 782 |
| Cost of stock option modifications and repricing | - | - | - | - | 68 | - | - | 68 |
| Issuance of common stock for cash | 120,087 | - | - | - | 339 | - | - | 339 |
| Common stock issued under equity award plans | 18,993 | - | - | - | 54 | - | - | 54 |
| Net loss during the three months ended June 30, 2026 | - | - | - | - | - | - | (9,471) | (9,471) |
| Balance, June 30, 2026 | 45,103,461 | $45 | (433,333) | $(433) | $318,440 | $(2) | $(301,937) | $16,113 |
| Additional · Accumulated Other | ||||||||
|---|---|---|---|---|---|---|---|---|
| Common Stock · Treasury Stock · Paid-in · Comprehensive · Accumulated | ||||||||
| Shares | Amount | Shares | Amount | Capital | Income (Loss) | Deficit | Total | |
| Balance, December 31, 2024 | 34,728,140 | $35 | (433,333) | $(433) | $278,001 | $64 | $(251,393) | 26,274 |
| Fair value of vested options | - | - | - | - | 1,423 | - | - | 1,423 |
| Unrealized loss on marketable securities | - | - | - | - | - | (35) | - | (35) |
| Fair value of vested restricted stock units | - | - | - | - | 103 | - | - | 103 |
| Cost of stock option repricing | - | - | - | - | 6 | - | - | 6 |
| Issuance of common stock for cash | 3,000,000 | 3 | - | - | 9,550 | - | - | 9,553 |
| Issuance of common stock upon exercise of stock options | 5,000 | - | - | - | 14 | - | - | 14 |
| Net loss during the three months ended March 31, 2025 | - | - | - | - | - | - | (7,492) | (7,492) |
| Balance, March 31, 2025 | 37,733,140 | $38 | (433,333) | $(433) | $289,097 | $29 | $(258,885) | $29,846 |
| Fair value of vested options | - | - | - | - | 1,290 | - | - | 1,290 |
| Unrealized loss on marketable securities | - | - | - | - | - | (26) | - | (26) |
| Fair value of vested restricted stock units | - | - | - | - | 185 | - | - | 185 |
| Cost of stock option modifications and repricing | - | - | - | - | 7 | - | - | 7 |
| Common stock issued under equity award plans | 25,876 | - | - | - | 52 | - | - | 52 |
| Net loss during the three months ended June 30, 2025 | - | - | - | - | - | - | (7,456) | (7,456) |
| Balance, June 30, 2025 | 37,759,016 | $38 | (433,333) | $(433) | $290,631 | $3 | $(266,341) | $23,898 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.